Series A Biotechnology Companies

Borealis Biosciences is a company in the field of next-generation RNA medicines.

Hervolution Therapeutics develops immunotherapies targeting tumors using Human Endogenous Retroviral proteins (HERVs).

Akamis Bio is a clinical-stage oncology company.

DeepLife uses deep learning on multi-omics data to model cells and efficiently engineer their behavior.

Tasca is a biotechnology company that offers small molecule drugs for hard-to-treat oncology indications.

Liom develops the ultimate wearable to monitor needle-free biomarkers, beginning with glucose.

Kapsera offers natural and innovative formulations for microbials based biofertilizers and biopesticides.

Doron Therapeutics is a clinical-stage biotechnology company that has developed intra-articular biologic drug derived from placental tissue.

Faircraft is leveraging advanced synthetic biology and material science techniques to develop a lab-grown alternative to animal leather.

Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients.

Ovagen is a biotechnology company.

Aralez Bio uses engineered enzymes to make valuable products in a sustainable way.

Next Generation Technology for Gastric Disorders

Sonavex is a developer of an imaging technology designed to visualize and quantify critical data to detect anastomotic blood clots.

MiLaboratories is a biotech company developing leading software platform for immune repertoire profiling

LoQus23 is a DDF-formed company focussing on targeting DNA damage repair pathways to treat Huntington's disease.

Arda is taking aim at chronic diseases and aging by eliminating the pathogenic cells that drive these conditions.

Mindpeak develops and distributes AI-based diagnostic software for the detection, quantification, and classification of cancer.

Sequentia Biotech is a bioinformatics company that offers services and tools that transform genomic data into knowledge.

Enzymit is a bioproduction platform company based on computational protein design and ‘cell-free' enzymatic manufacturing technology

NIO develops sustainable alternatives to animal fats, palm and coconut oil.

LIfT Biosciences® a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy

Eradivir is a biotech company that aims to develop a non-immunological targeting agent for use against the virus that causes COVID-19.

Synex Medical develops non-invasive blood testing technology.

GC Therapeutics uses synthetic biology to program patient-derived stem cells into various cell types in an efficient and scalable manner.